Istios Health Expands Infectious Disease Research Network Through Strategic Partnerships in Georgia and Virginia
核心洞察
Istios Health (搜索) announced strategic partnerships with Infectious Disease Consultants of Georgia (搜索) and Infectious Disease Associates of Central Virginia (搜索) to expand its nationwide network of ID practices and clinical research sites.
The partnerships enable broader patient access to clinical trials and accelerate development of new treatments across infectious diseases through Istios' ID Navigator platform.
IDCGA operates four outpatient locations across greater Atlanta while IDACV delivers care through hospitals, outpatient clinics, and four infusion centers in central Virginia.
Istios Health (搜索), a healthcare technology company transforming infectious disease (搜索) care through integrated clinical services and research-enabled networks, has announced two strategic partnerships that significantly expand its nationwide network of infectious disease practices and clinical research sites. The company partnered with Infectious Disease Consultants of Georgia (搜索) (IDCGA) in August 2025 and Infectious Disease Associates of Central Virginia (搜索) (IDACV) in September 2025.
Strategic Network Expansion
The partnerships mark Istios Health (搜索)'s official entry into the Georgia market and further expansion in Virginia, strengthening its dual mission of advancing drug discovery and development while delivering high-quality virtual infectious disease (搜索) care. Both partnerships enable the participating practices to maintain clinical autonomy while leveraging Istios Health's national infrastructure.
"We are thrilled to partner with a preeminent group of physicians and researchers to build upon our integrated clinical research site network and pioneer infectious disease (搜索) medicine nationally," said Nikos Nikolopoulos, CEO and co-founder of Istios Health (搜索). "IDCGA's clinical expertise, research infrastructure, deep community connections and reputation for quality and outcomes make them an ideal partner for the Istios high performing network."
Enhanced Research Capabilities
Under the partnerships, both practices will leverage Istios Health (搜索)'s ID Navigator platform, designed to streamline specialty care delivery and optimize participation in real-world research and clinical trials. The platform enables research sponsors to reach broader and more diverse patient populations, accelerating the development and evaluation of new treatments across a wide range of infectious diseases.
"This partnership represents an exciting step in building a truly national network of infectious disease (搜索) specialists united around research, innovation, and quality patient care," said Nikolopoulos regarding the IDACV partnership. "IDACVs respected physicians, strong community ties, and proven track record in both care delivery and research make them a natural fit for the Istios platform."
Practice Profiles and Capabilities
IDCGA operates four outpatient locations across the greater Atlanta area in Suwanee, Lawrenceville, Athens, and Dacula. The group's physicians are dual-board-certified in infectious disease (搜索) and internal medicine, bringing decades of combined expertise in infection management, IV infusion therapy, chronic care management, IVIG treatments, and clinical infectious disease research.
IDACV delivers comprehensive infectious disease (搜索) care across hospitals, outpatient clinics, and four infusion centers in central Virginia. Its physicians are board-certified in infectious disease and internal medicine, offering expertise in infection management, IV infusion therapy, chronic disease management, HIV (搜索) and hepatitis (搜索) treatment, and clinical infectious disease research.
Both practices have dedicated research teams that have participated in numerous clinical trials, contributing to the development of advanced therapies that improve patient outcomes and combat emerging infectious threats.
Clinical Research Focus
Istios Health (搜索)'s research division partners with sponsors and clinical research organizations to bring cutting-edge treatments to patients and generate actionable data to advance the field. The company focuses predominantly on Phase II-IV clinical research trials and now manages a network of 7 clinical research sites across several states.
"We see this as a tremendous opportunity to enhance the care we provide our patients while playing a larger role in shaping the future of infectious disease (搜索) medicine," said Dr. Brennan, a lead physician at IDACV. "Partnering with Istios allows us to bring more research opportunities to Virginia, expand access to innovative therapies, and contribute meaningfully to national efforts against infectious threats."
Technology Integration
The partnerships integrate telehealth, real-world evidence, and clinical infrastructure to improve care quality, expand access, and drive innovation in infectious disease (搜索) medicine. The ID Navigator platform supports seamless specialty care coordination and enables efficient participation in clinical trials and real-world evidence programs.
"This partnership reflects a shared commitment to delivering high-quality, patient-centered ID care while advancing innovation through research," said Dr. Spires, a lead physician at IDCGA. "By joining Istios, we can amplify our impact across Georgia and contribute to national efforts to combat infectious threats with data-driven precision."